GREEN CATHeter Lab Study
GREEN-CATH
Assessing Waste and Environmental Impact in Catheterization Laboratories: Results From the GREEN CATHeter Lab Study
1 other identifier
observational
40
1 country
1
Brief Summary
This study involves the prospective quantification and classification of waste produced during interventional cardiology procedures. For each included case, the total waste generated will be measured in kilograms immediately after completion of the procedure. Waste will be physically sorted and recorded by category in accordance with four predefined waste types: (i) paper and cardboard, (ii) regular waste (i.e., municipal solid waste or general trash), (iii) regulated medical waste (requiring specialized incineration including sharpsafe), and (iv) recyclable plastic. Based on two models ("Basel Model" and "Standard Model"), the study will perform scenario-based calculations to compare the environmental and economic impact of both strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 21, 2025
CompletedFirst Posted
Study publicly available on registry
August 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 3, 2025
CompletedMarch 5, 2026
March 1, 2026
4 months
July 21, 2025
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Total amount of waste (kilogram) generated per cardiac intervention- procedure type
The waste will be weighed using a certified, hospital-grade scale provided by the in-house hospital pharmacy (Beurer, Typ KS 59, max 20 kg).
one time assessment immediately after cardiac intervention
Composition of waste (by waste category) generated per cardiac intervention- procedure type
Waste will be physically sorted and recorded by category in accordance with four predefined waste types: (i) paper and cardboard, (ii) regular waste (i.e., municipal solid waste or general trash), (iii) regulated medical waste (requiring specialized incineration including sharpsafe), and (iv) recyclable plastic.
one time assessment immediately after cardiac intervention
Relation of waste output to the average daily waste production of a Swiss resident (in kilogram)
Relation of waste output generated per cardiac intervention- procedure type to the average daily waste production of a Swiss resident (in kilogram)
one time assessment immediately after cardiac intervention
Relation of waste output to the average daily waste production of a typical inhospital patient (in kilogram)
Relation of waste output generated per cardiac intervention- procedure type to the average daily waste production of a typical inhospital patient (in kilogram)
one time assessment immediately after cardiac intervention
Secondary Outcomes (3)
Comparison of environmental impact by CO₂ emissions
Postprocedural (one time assessment after cardiac intervention)
Comparison of environmental impact by disposal costs (in Swiss Francs)
Postprocedural (one time assessment after cardiac intervention)
Ecological burden by ReCiPe score
Postprocedural (one time assessment after cardiac intervention)
Study Arms (4)
Elective diagnostic coronary angiography
Elective diagnostic coronary angiography with or without simple PCI
Complex percutaneous coronary interventions (PCI) procedures
Complex PCI procedures, including CTO, CHIP, or patients in cardiogenic shock requiring temporary mechanical circulatory support with an Impella device
Structural heart intervention: transcatheter aortic valve implantation (TAVI)
Structural heart intervention: TAVI
Structural heart interventions: transcatheter edge-to-edge repair (TEER)
Structural heart interventions: TEER of the mitral or tricuspid valves (MitraClip or TriClip systems)
Interventions
For each included case, the total waste generated will be measured in kilograms immediately after completion of the procedure and physically recorded by category in accordance with four predefined waste types: (i) paper and cardboard, (ii) regular waste (i.e., municipal solid waste or general trash), (iii) regulated medical waste (requiring specialized incineration including sharpsafe), and (iv) recyclable plastic
Simulation of a hypothetical but common practice in many hospitals, in which all waste generated during interventional procedures is disposed of as regulated medical waste, without separation.
Eligibility Criteria
The study "population" includes the following interventional procedures on scheduled audit days: (i) elective diagnostic coronary angiography with or without simple PCI, (ii) complex PCI procedures, including CTO, CHIP, or patients in cardiogenic shock requiring temporary mechanical circulatory support with an Impella device, (iii) TAVI, and (iv) TEER of the mitral or tricuspid valves, such as with MitraClip or TriClip systems. A minimum of ten cases per procedure type will be targeted to ensure adequate comparisons. All patients undergoing the above-listed procedures during the defined measurement days are eligible for inclusion
You may qualify if:
- All patients undergoing the following interventional procedures:
- o Elective diagnostic coronary angiography
- with PCI
- without PCI
- Complex percutaneous coronary interventions (CTO, CHIP, or patients with cardiogenic shock requiring Impella support)
- Structural heart intervention: TAVI
- Structural heart interventions: TEER of the mitral or tricuspid valve (MitraClip or TriClip)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Cardiology, University Heart Center Basel, University Hospital Basel
Basel, 4031, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Jasper Boeddinghaus, PD Dr. med.
Department of Cardiology, University Heart Center Basel, University Hospital Basel
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2025
First Posted
August 6, 2025
Study Start
May 1, 2025
Primary Completion
September 3, 2025
Study Completion
September 3, 2025
Last Updated
March 5, 2026
Record last verified: 2026-03